Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 23 09:36AM ET
23.47
Dollar change
+2.08
Percentage change
9.70
%
IndexRUT P/E216.67 EPS (ttm)0.11 Insider Own45.58% Shs Outstand70.94M Perf Week4.99%
Market Cap1.66B Forward P/E40.16 EPS next Y0.58 Insider Trans-0.40% Shs Float38.61M Perf Month26.09%
Income8.65M PEG- EPS next Q-0.08 Inst Own51.62% Short Float12.08% Perf Quarter37.26%
Sales301.77M P/S5.52 EPS this Y-176.99% Inst Trans-0.13% Short Ratio11.79 Perf Half Y21.71%
Book/sh6.50 P/B3.61 EPS next Y479.44% ROA1.80% Short Interest4.66M Perf Year50.51%
Cash/sh3.01 P/C7.79 EPS next 5Y- ROE2.10% 52W Range14.12 - 22.65 Perf YTD33.78%
Dividend Est.- P/FCF77.93 EPS past 5Y- ROI1.96% 52W High3.60% Beta0.38
Dividend TTM- Quick Ratio3.79 Sales past 5Y98.80% Gross Margin64.07% 52W Low66.18% ATR (14)0.84
Dividend Ex-Date- Current Ratio4.21 EPS Y/Y TTM-95.59% Oper. Margin-10.12% RSI (14)73.00 Volatility3.58% 3.79%
Employees297 Debt/Eq0.03 Sales Y/Y TTM27.69% Profit Margin2.87% Recom1.00 Target Price30.67
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-42.47% Payout0.00% Rel Volume6.81 Prev Close21.39
Sales Surprise3.80% EPS Surprise-204.51% Sales Q/Q65.18% EarningsJul 23 BMO Avg Volume395.58K Price23.47
SMA2016.87% SMA5020.06% SMA20027.44% Trades Volume173,957 Change9.70%
Date Action Analyst Rating Change Price Target Change
May-03-24Initiated Wells Fargo Overweight $34
Jun-29-20Reiterated BofA Securities Buy $25 → $40
Apr-01-20Initiated BofA/Merrill Buy $25
Mar-11-19Initiated Barclays Overweight $26
Dec-12-18Reiterated Wedbush Outperform $31 → $33
Jun-19-18Initiated JMP Securities Mkt Outperform $33
Today 07:30AM
Jul-16-24 04:01PM
Jul-09-24 08:00AM
08:00AM
Jun-24-24 08:00AM
08:30AM Loading…
Jun-17-24 08:30AM
Jun-04-24 04:01PM
Jun-03-24 07:00AM
May-07-24 04:01PM
Apr-24-24 09:00AM
Apr-23-24 11:53AM
08:53AM
08:40AM
08:36AM
07:30AM
04:01PM Loading…
Apr-16-24 04:01PM
Apr-02-24 07:30AM
Mar-01-24 09:55AM
Feb-29-24 11:33PM
12:00PM
09:21AM
Feb-28-24 08:50AM
08:40AM
07:52AM
07:30AM
Feb-21-24 04:01PM
Feb-12-24 09:55AM
08:50AM
Jan-23-24 09:55AM
08:50AM
08:46AM Loading…
Jan-09-24 08:46AM
Jan-04-24 07:30AM
Jan-02-24 04:01PM
Dec-23-23 09:00AM
Dec-15-23 02:30PM
Nov-24-23 02:05PM
Nov-20-23 09:55AM
Nov-09-23 10:01PM
Nov-01-23 08:27AM
Oct-31-23 10:48PM
08:50AM
07:30AM
Oct-24-23 04:01PM
Oct-20-23 12:08PM
Sep-29-23 12:43PM
Aug-27-23 08:40AM
Aug-22-23 08:14AM
Aug-18-23 09:04PM
Aug-10-23 10:33PM
Aug-07-23 06:14AM
Jul-25-23 10:05PM
01:06PM
08:45AM
07:30AM
Jul-24-23 08:31AM
Jul-18-23 04:01PM
Jul-17-23 08:00AM
Jul-04-23 08:24PM
Jun-06-23 04:01PM
May-03-23 06:14AM
May-02-23 08:45AM
07:30AM
May-01-23 04:01PM
Apr-09-23 09:21AM
Apr-05-23 01:40PM
Mar-31-23 09:35AM
Mar-30-23 02:20PM
Mar-29-23 10:13AM
Mar-27-23 12:04PM
Mar-23-23 02:25PM
Mar-03-23 06:57PM
Feb-28-23 11:25AM
08:00AM
Feb-27-23 04:01PM
11:47AM
Feb-23-23 10:50AM
Jan-25-23 02:52AM
Jan-21-23 04:51PM
Jan-09-23 08:00AM
Jan-03-23 04:01PM
Nov-30-22 04:01PM
Nov-23-22 04:01PM
Nov-10-22 09:40AM
Nov-07-22 09:55AM
08:50AM
Nov-01-22 09:15AM
08:00AM
Oct-31-22 04:01PM
Oct-24-22 09:40AM
Oct-05-22 08:50AM
Sep-21-22 12:00PM
Sep-20-22 10:30AM
Sep-12-22 08:30AM
Aug-22-22 09:55AM
Aug-05-22 09:55AM
Aug-04-22 09:09AM
Aug-03-22 04:01PM
09:40AM
08:45AM
08:30AM
Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Sanj KCHAIRMAN & CEOMar 07 '24Sale21.0265,0121,366,5520Mar 11 07:05 PM
Patel Sanj KCHAIRMAN & CEOMar 06 '24Sale21.005,582117,22265,012Mar 06 05:37 PM
Patel Sanj KCHAIRMAN & CEOMar 04 '24Sale21.4912,742273,83470,594Mar 06 05:37 PM
Megna Michael RCHIEF ACCOUNTING OFFICERMar 01 '24Option Exercise10.939,659105,56027,247Mar 01 06:26 PM
Paolini John F.CHIEF MEDICAL OFFICERMar 01 '24Option Exercise1.8618,84435,05062,736Mar 05 04:31 PM
Tessari EbenCHIEF OPERATING OFFICERMar 01 '24Option Exercise1.596561,043124,036Mar 05 04:34 PM
Paolini John F.CHIEF MEDICAL OFFICERMar 01 '24Sale21.7718,844410,23444,892Mar 05 04:31 PM
Megna Michael RCHIEF ACCOUNTING OFFICERMar 01 '24Sale21.459,659207,18617,588Mar 01 06:26 PM
Tessari EbenCHIEF OPERATING OFFICERMar 01 '24Sale22.031,18926,194122,847Mar 05 04:34 PM
Megna Michael RCHIEF ACCOUNTING OFFICERFeb 28 '24Option Exercise8.835,12645,26322,714Mar 01 06:26 PM
Megna Michael RCHIEF ACCOUNTING OFFICERFeb 28 '24Sale21.795,126111,69617,588Mar 01 06:26 PM
Paolini John F.CHIEF MEDICAL OFFICERFeb 27 '24Option Exercise1.8610,15618,89055,048Feb 29 04:26 PM
Paolini John F.CHIEF MEDICAL OFFICERFeb 27 '24Sale21.0310,156213,58144,892Feb 29 04:26 PM
Ragosa MarkCHIEF FINANCIAL OFFICERJan 03 '24Option Exercise8.8312,000105,96027,632Jan 04 04:30 PM
Ragosa MarkCHIEF FINANCIAL OFFICERJan 03 '24Sale20.0012,000240,00015,632Jan 04 04:30 PM
Megna Michael RCHIEF ACCOUNTING OFFICERJan 02 '24Option Exercise13.8816,670231,38033,675Jan 04 04:30 PM
Megna Michael RCHIEF ACCOUNTING OFFICERJan 02 '24Sale19.1716,670319,56417,005Jan 04 04:30 PM
Megna Michael RCHIEF ACCOUNTING OFFICERDec 19 '23Option Exercise13.889,316129,30626,321Dec 21 04:26 PM
Megna Michael RCHIEF ACCOUNTING OFFICERDec 19 '23Sale19.139,316178,21517,005Dec 21 04:26 PM
Paolini John F.CHIEF MEDICAL OFFICERDec 07 '23Option Exercise1.8628,60053,19673,492Dec 11 04:20 PM
Paolini John F.CHIEF MEDICAL OFFICERDec 07 '23Sale17.6528,600504,75844,892Dec 11 04:20 PM
Paolini John F.CHIEF MEDICAL OFFICERSep 05 '23Option Exercise1.8640074445,292Sep 06 07:03 PM
Paolini John F.CHIEF MEDICAL OFFICERSep 05 '23Sale17.534007,01244,892Sep 06 07:03 PM
Paolini John F.CHIEF MEDICAL OFFICERJul 25 '23Option Exercise1.8629,00053,94070,910Jul 27 04:30 PM
Paolini John F.CHIEF MEDICAL OFFICERJul 25 '23Sale19.1429,000555,16041,910Jul 27 04:30 PM